ArticlePolymers2025
Dual Role of Ionic Liquids as Plasticizer and Co-Foaming Agent of Polylactide Matrix.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Tailoring PLA-Based Composite Membranes with Ionic Liquids for Efficient HMaterials (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Polylactic acid (PLA) is considered as an attractive polymer due to its renewable origin, biodegradability, and promising tensile strength and modulus. However, its inherent brittleness, characterized by a low impact resistance and elongation at break, can significantly restrict its application. This work proposes a new insight to improve the toughness of PLA while keeping its biocompatibility by incorporating two biocompatible ionic liquids (ILs), 1-ethyl-3-methylimidazolium ethyl sulfate ([emim][EtSO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.